Magnetar Financial’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Magnetar Financial’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,679,600	Closed	-$80.6M	–	641
2020 Q1	$80.6M	Sell	1,679,600 -158,906	-9%	-$7.39M	1.94%	17
2019 Q4	$86.3M	Buy	+1,838,506	New	+$81.3M	1.8%	14
2018 Q1	–	Sell	-21,844	Closed	-$186K	–	858
2017 Q4	$186K	Buy	+21,844	New	+$269K	﹤0.01%	639

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Magnetar Financial's RARX Position: Q2 2020 in Review

Magnetar Financial sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 1,679,600 shares — an estimated $80.6M sold.

Magnetar Financial first reported a position in RARX in Q4 2017 and held it in 3 quarters. The position peaked at $86.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Magnetar Financial reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Magnetar Financial sold 1,679,600 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $80.6M.
Magnetar Financial first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Magnetar Financial's Ra Pharmaceuticals, Inc. Common Stock position peaked at $86.3M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Magnetar Financial's 13F filing for Q2 2020, filed 14 Aug 2020.